Viridian Therapeutics Shares Are Trading Higher After BTIG Raised Its Price Target on the Stock From $56 to $61.
Viridian Therapeutics Shares Are Trading Higher After BTIG Raised Its Price Target on the Stock From $56 to $61.
Viridian Therapeutics股價上漲，原因是BTIG將其股價目標從56美元上調至61美元。
Viridian Therapeutics Shares Are Trading Higher After BTIG Raised Its Price Target on the Stock From $56 to $61.
Viridian Therapeutics股票交易走高，BTIG將其股票價格目標從56美元上調至61美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。